The decision to prioritise Nigeria for future malaria vaccine distribution will bridge a crucial healthcare gap in the nation’s battle against the pervasive disease.
Scientists make groundbreaking discovery of Paenibacillus thiaminolyticus bacteria responsible for alarming newborn mortality in Uganda, leading to potential advances in diagnosis and treatment.
Despite contributing over 30 per cent of the malaria disease burden on the African continent, Nigeria has missed out of 18 million doses of first-ever malaria vaccines allocated to 12 African countries for 2023 to 2025.